Billions at risk as Medicare opens to weight-loss medications and presses competitors with Novo Nordisk.
发布者:BY ALBERT RONNING-ANDERSSON,转转请注明出处:https://robotalks.cn/eli-lilly-ceo-uncertain-slimming-drug-demand-makes-2026-plans-hard-to-set/
Billions at risk as Medicare opens to weight-loss medications and presses competitors with Novo Nordisk.
发布者:BY ALBERT RONNING-ANDERSSON,转转请注明出处:https://robotalks.cn/eli-lilly-ceo-uncertain-slimming-drug-demand-makes-2026-plans-hard-to-set/